TY  - RPRT
TI  - Improving the preclinical and clinical success rates of LMW drugs depends on radical revisions to the status quo scientific foundations of medicinal chemistry: a case study on COVID Mpro inhibition
AU  - Pearlstein, R. A.
AU  - Wan, H.
AU  - Williams, S.
PY  - 2022
DO  - 10.1101/2022.10.31.514572
UR  - https://www.biorxiv.org/content/10.1101/2022.10.31.514572v1
ID  - 10.1101/2022.10.31.514572
ER  -